Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

AMRZ vs LIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AMRZ
Amrize Ltd

Construction Materials

Basic MaterialsNYSE • CH
Market Cap$31.16B
5Y Perf.+10.9%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$232.56B
5Y Perf.+7.0%

AMRZ vs LIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AMRZ logoAMRZ
LIN logoLIN
IndustryConstruction MaterialsChemicals - Specialty
Market Cap$31.16B$232.56B
Revenue (TTM)$11.81B$34.66B
Net Income (TTM)$1.22B$7.13B
Gross Margin25.7%46.0%
Operating Margin16.1%28.8%
Forward P/E19.6x28.1x
Total Debt$5.91B$26.99B
Cash & Equiv.$1.92B$5.06B

AMRZ vs LINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AMRZ
LIN
StockJun 25May 26Return
Amrize Ltd (AMRZ)100110.9+10.9%
Linde plc (LIN)100107.0+7.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: AMRZ vs LIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Amrize Ltd is the stronger pick specifically for valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
AMRZ
Amrize Ltd
The Defensive Pick

AMRZ is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.32, Low D/E 44.6%, current ratio 1.64x
  • Lower P/E (19.6x vs 28.1x)
Best for: sleep-well-at-night
LIN
Linde plc
The Income Pick

LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 6 yrs, beta 0.24, yield 1.2%
  • Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
  • 376.9% 10Y total return vs AMRZ's 6.5%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLIN logoLIN3.0% revenue growth vs AMRZ's 0.9%
ValueAMRZ logoAMRZLower P/E (19.6x vs 28.1x)
Quality / MarginsLIN logoLIN20.6% margin vs AMRZ's 10.3%
Stability / SafetyLIN logoLINBeta 0.24 vs AMRZ's 1.32
DividendsLIN logoLIN1.2% yield; 6-year raise streak; the other pay no meaningful dividend
Momentum (1Y)LIN logoLIN+13.6% vs AMRZ's +6.5%
Efficiency (ROA)LIN logoLIN8.3% ROA vs AMRZ's 5.0%, ROIC 11.3% vs 9.2%

AMRZ vs LIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AMRZAmrize Ltd
FY 2025
Building Materials
100.0%$8.5B
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B

AMRZ vs LIN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLINLAGGINGAMRZ

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 6 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 2.9x AMRZ's $11.8B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to AMRZ's 10.3%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
RevenueTrailing 12 months$11.8B$34.7B
EBITDAEarnings before interest/tax$2.8B$12.1B
Net IncomeAfter-tax profit$1.2B$7.1B
Free Cash FlowCash after capex$1.4B$5.1B
Gross MarginGross profit ÷ Revenue+25.7%+46.0%
Operating MarginEBIT ÷ Revenue+16.1%+28.8%
Net MarginNet income ÷ Revenue+10.3%+20.6%
FCF MarginFCF ÷ Revenue+12.0%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%+8.2%
EPS Growth (YoY)Latest quarter vs prior year-34.9%+13.4%
LIN leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

AMRZ leads this category, winning 6 of 6 comparable metrics.

At 25.7x trailing earnings, AMRZ trades at a 25% valuation discount to LIN's 34.4x P/E. On an enterprise value basis, AMRZ's 12.5x EV/EBITDA is more attractive than LIN's 20.0x.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
Market CapShares × price$31.2B$232.6B
Enterprise ValueMkt cap + debt − cash$35.1B$254.5B
Trailing P/EPrice ÷ TTM EPS25.68x34.40x
Forward P/EPrice ÷ next-FY EPS est.19.60x28.12x
PEG RatioP/E ÷ EPS growth rate1.36x
EV / EBITDAEnterprise value multiple12.46x20.04x
Price / SalesMarket cap ÷ Revenue2.64x6.84x
Price / BookPrice ÷ Book value/share2.30x5.92x
Price / FCFMarket cap ÷ FCF21.94x45.70x
AMRZ leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

LIN leads this category, winning 6 of 9 comparable metrics.

LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $9 for AMRZ. AMRZ carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs AMRZ's 3/9, reflecting solid financial health.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
ROE (TTM)Return on equity+9.2%+17.8%
ROA (TTM)Return on assets+5.0%+8.3%
ROICReturn on invested capital+9.2%+11.3%
ROCEReturn on capital employed+8.9%+13.0%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.45x0.68x
Net DebtTotal debt minus cash$4.0B$21.9B
Cash & Equiv.Liquid assets$1.9B$5.1B
Total DebtShort + long-term debt$5.9B$27.0B
Interest CoverageEBIT ÷ Interest expense5.23x34.52x
LIN leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LIN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $10,654 for AMRZ. Over the past 12 months, LIN leads with a +13.6% total return vs AMRZ's +6.5%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs AMRZ's 2.1% — a key indicator of consistent wealth creation.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
YTD ReturnYear-to-date-0.1%+17.3%
1-Year ReturnPast 12 months+6.5%+13.6%
3-Year ReturnCumulative with dividends+6.5%+41.9%
5-Year ReturnCumulative with dividends+6.5%+78.1%
10-Year ReturnCumulative with dividends+6.5%+376.9%
CAGR (3Y)Annualised 3-year return+2.1%+12.4%
LIN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than AMRZ's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs AMRZ's 83.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
Beta (5Y)Sensitivity to S&P 5001.32x0.24x
52-Week HighHighest price in past year$65.94$521.28
52-Week LowLowest price in past year$44.12$387.78
% of 52W HighCurrent price vs 52-week peak+83.3%+96.3%
RSI (14)Momentum oscillator 0–10041.350.6
Avg Volume (50D)Average daily shares traded2.8M2.3M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates AMRZ as "Buy" and LIN as "Buy". Consensus price targets imply 20.3% upside for AMRZ (target: $66) vs 7.5% for LIN (target: $540). LIN is the only dividend payer here at 1.20% yield — a key consideration for income-focused portfolios.

MetricAMRZ logoAMRZAmrize LtdLIN logoLINLinde plc
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$66.11$539.71
# AnalystsCovering analysts728
Dividend YieldAnnual dividend ÷ price+1.2%
Dividend StreakConsecutive years of raises6
Dividend / ShareAnnual DPS$6.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.0%
Insufficient data to determine a leader in this category.
Key Takeaway

LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMRZ leads in 1 (Valuation Metrics).

Best OverallLinde plc (LIN)Leads 4 of 6 categories
Loading custom metrics...

AMRZ vs LIN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is AMRZ or LIN a better buy right now?

For growth investors, Linde plc (LIN) is the stronger pick with 3.

0% revenue growth year-over-year, versus 0. 9% for Amrize Ltd (AMRZ). Amrize Ltd (AMRZ) offers the better valuation at 25. 7x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Amrize Ltd (AMRZ) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AMRZ or LIN?

On trailing P/E, Amrize Ltd (AMRZ) is the cheapest at 25.

7x versus Linde plc at 34. 4x. On forward P/E, Amrize Ltd is actually cheaper at 19. 6x.

03

Which is the better long-term investment — AMRZ or LIN?

Over the past 5 years, Linde plc (LIN) delivered a total return of +78.

1%, compared to +6. 5% for Amrize Ltd (AMRZ). Over 10 years, the gap is even starker: LIN returned +376. 9% versus AMRZ's +6. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AMRZ or LIN?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Amrize Ltd's 1. 32β — meaning AMRZ is approximately 449% more volatile than LIN relative to the S&P 500. On balance sheet safety, Amrize Ltd (AMRZ) carries a lower debt/equity ratio of 45% versus 68% for Linde plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — AMRZ or LIN?

By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.

0% versus 0. 9% for Amrize Ltd (AMRZ). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -7. 0% for Amrize Ltd. Over a 3-year CAGR, AMRZ leads at 3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AMRZ or LIN?

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus 10. 0% for Amrize Ltd — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 16. 1% for AMRZ. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AMRZ or LIN more undervalued right now?

On forward earnings alone, Amrize Ltd (AMRZ) trades at 19.

6x forward P/E versus 28. 1x for Linde plc — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMRZ: 20. 3% to $66. 11.

08

Which pays a better dividend — AMRZ or LIN?

In this comparison, LIN (1.

2% yield) pays a dividend. AMRZ does not pay a meaningful dividend and should not be held primarily for income.

09

Is AMRZ or LIN better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, AMRZ: +6. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AMRZ and LIN?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

LIN pays a dividend while AMRZ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

AMRZ

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AMRZ and LIN on the metrics below

Revenue Growth>
%
(AMRZ: -0.4% · LIN: 8.2%)
Net Margin>
%
(AMRZ: 10.3% · LIN: 20.6%)
P/E Ratio<
x
(AMRZ: 25.7x · LIN: 34.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.